Home > Boards > US Listed > Biotechs > ImmunoGen, Inc. (IMGN)

Xena,Are you anticipating something before we get updates

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
skitahoe Member Profile
 
Followed By 159
Posts 7,627
Boards Moderated 0
Alias Born 08/14/03
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2021 4:07:48 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/12/2021 10:12:13 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/9/2021 4:11:37 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/9/2021 4:11:11 PM
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 8/2/2021 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/30/2021 5:13:16 PM
ImmunoGen posts wider Q2 net loss as R&D expenses ramp Seeking Alpha - 7/30/2021 7:50:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2021 6:37:33 AM
ImmunoGen EPS beats by $0.03, misses on revenue Seeking Alpha - 7/30/2021 6:36:14 AM
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results Business Wire - 7/30/2021 6:30:00 AM
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating Results Business Wire - 7/15/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:25:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:23:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:23:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:21:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:21:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:20:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:19:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:18:36 PM
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 7/1/2021 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2021 4:26:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2021 4:24:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2021 4:24:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2021 4:14:11 PM
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 6/1/2021 4:30:00 PM
skitahoe   Friday, 02/05/21 03:35:29 PM
Re: XenaLives post# 708
Post # of 743 
Xena,

Are you anticipating something before we get updates on the clinical trials later this year. I suppose a partnership is possible at any time, I've not heard anything rumored near term.

Thanks,

Gary

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences